Systemic inflamatory reaction following pleurodesis with talk surray

M. Lerikou, G. Antoniou, D. Hajhilia, M. Zontanos, G. Pavlakou, P. Demertzis, O. Anagnostopoulou (Athens, Greece)

Source: Annual Congress 2008 - Therapy of thoracic tumours
Session: Therapy of thoracic tumours
Session type: E-Communication Session
Number: 4304

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Lerikou, G. Antoniou, D. Hajhilia, M. Zontanos, G. Pavlakou, P. Demertzis, O. Anagnostopoulou (Athens, Greece). Systemic inflamatory reaction following pleurodesis with talk surray. Eur Respir J 2008; 32: Suppl. 52, 4304

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Talc poudrage during thoracoscopy induces fever and systemic inflammatory reaction
Source: Eur Respir J 2005; 26: Suppl. 49, 317s
Year: 2005

Systemic inflammatory reactions in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

Systemic inflammatory repercussions after pleurodesis in an experimental model of pneumothorax
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013


Systemic treatment
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis
Source: Eur Respir J 2006; 28: 929-932
Year: 2006



Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success?
Source: Eur Respir Rev 2011; 20: 218-219
Year: 2011


Systemic manifestations of sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

Acute inflammatory response secondary to intrapleural administration of two types of talc
Source: Eur Respir J 2010; 35: 396-401
Year: 2010



Are there any predictors of MTX response in progressive pulmonary sarcoidosis?
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Granulomatous reaction in a patient with lung cancer: should we treat it?
Source: Breathe, 14 (3) e94; 10.1183/20734735.014617
Year: 2018



Systemic inflammation in OSA
Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP
Year: 2009



Short-term respiratory and systemic inflammatory responses to welding exposure
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Non specific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia: repair or remodeling process?
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis
Source: Eur Respir J 2006; 27: 817-821
Year: 2006



Systemic treatment: an adjuvant indication?
Source: Annual Congress 2004 - Lung metastases
Year: 2004

Improvement in SARS-CoV2 lung interstitial injuries with systemic corticosteroid treatment
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Interstitial lung disease in systemic sclerosis: where do we stand?
Source: Eur Respir Rev 2015; 24: 411-419
Year: 2015



Molecular-cellular features of macrophage reaction in granulomatous pulmonary diseases
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007


Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases
Source: Breathe, 16 (4) 200203; 10.1183/20734735.0203-2020
Year: 2020



Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: Eur Respir J 2014; 44: 1096-1098
Year: 2014